Article
Genetics of Myeloproliferative Neoplasms.
Hematology/oncology clinics of North America - 1 Apr 2021
Szybinski Jakub, Meyer Sara C
Abstract excerpt
Myeloproliferative neoplasms are hematopoietic stem cell disorders based on somatic mutations in JAK2, calreticulin, or MPL activating JAK-STAT signaling. Modern sequencing efforts have revealed the genomic landscape of myeloproliferative neoplasms with additional genetic alterations mainly in epigenetic modifiers and splicing factors. High molecular risk mutations with adverse outcomes have been identified and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
